Biblio Discovery — Demo Discovery Service

42 hasil

Menampilkan 1–20 · 0,15 detik · RSS

Jurnal

npj Drug Discovery

ISSN 3005-1452 · Nature Portfolio · 42 artikel di indeks

  1. Artikel Jurnal

    Development of potent, selective cPLA2 inhibitors for targeting neuroinflammation in Alzheimer’s disease and other neurodegenerative disorders

    Anastasiia V. Sadybekov; Marlon Vincent Duro; Shaowei Wang dkk.

    npj Drug Discovery, Vol. 3 No. 1 · 2026 · Inggris · DOAJ

    Abstract Chronic neuroinflammation plays a key role in the progression of Alzheimer’s disease (AD), and the cytosolic calcium-dependent phospholipase A2 (cPLA2) enzyme is a critical mediator of inflammatory lipid signaling pathways. Here we investigate the therapeutic potential of novel cPLA2…

  2. Artikel Jurnal

    Quantum-machine-assisted drug discovery

    Yidong Zhou; Jintai Chen; Jinglei Cheng dkk.

    npj Drug Discovery, Vol. 3 No. 1 · 2026 · Inggris · DOAJ

    Abstract Drug discovery is lengthy and expensive, with traditional computer-aided design facing limits. This paper examines integrating quantum computing across the drug development cycle to accelerate and enhance workflows and rigorous decision-making. It highlights quantum approaches for…

  3. Artikel Jurnal

    Interaction-constrained 3D molecular generation using a diffusion model enables structure-based pharmacophore modeling for drug design

    Masami Sako; Nobuaki Yasuo; Masakazu Sekijima

    npj Drug Discovery, Vol. 3 No. 1 · 2026 · Inggris · DOAJ

    Abstract A key challenge in structure-based drug design is generating three-dimensional molecules while preserving essential protein-ligand interactions. We propose DiffPharma, a structure-based pharmacophore modeling framework based on a conditional diffusion model, to generate molecules that…

  4. Artikel Jurnal

    Preferential HER4 stimulation preserves neuregulin-induced improvement of myocardial function

    Samuel L. Murphy; Wai Hong Wilson Tang; Xiaolei Zhuang dkk.

    npj Drug Discovery, Vol. 3 No. 1 · 2026 · Inggris · DOAJ

    Abstract Neuregulin-1 (NRG-1), the natural ligand for HER3 and HER4, has been established as an essential growth factor for heart function. Prior studies have demonstrated the therapeutic potential of NRG-1 in the treatment of heart failure, but HER3 receptor activation has been a concern given its…

  5. Artikel Jurnal

    Vector venom: venomics of Aedes albopictus reveals a large enzyme repertoire and novel cecropins with activity against E. coli

    Ludwig Dersch; Jonas Krämer; Sabine Hurka dkk.

    npj Drug Discovery, Vol. 3 No. 1 · 2026 · Inggris · DOAJ

    Abstract Mosquitoes are vectors of deadly diseases and pose a global health threat. Particularly, the Asian tiger mosquito Aedes albopictus can transmit several pathogens, and is expanding into temperate regions. During blood feeding, mosquitoes inject chemically complex saliva, here referred to as…

  6. Artikel Jurnal

    Innovation breakthrough in the Alzheimer’s disease pharmaceutical industry

    Hua Cheng; Leyi Kang; Yulong Xu dkk.

    npj Drug Discovery, Vol. 3 No. 1 · 2026 · Inggris · DOAJ

    Abstract Alzheimer’s disease (AD) drug development has undergone cycles, driven initially by amyloid-β–based hypotheses and later setbacks by clinical failures. Recent advances in biotechnology, improved understanding of AD pathogenesis, and unmet medical needs have revitalized the field. This new…

  7. Artikel Jurnal

    Advancements in RNA-based therapies from bench to bedside

    Amrita Singh; Muktika Tekade; Sreeharsha Nagaraja dkk.

    npj Drug Discovery, Vol. 3 No. 1 · 2026 · Inggris · DOAJ

    Abstract RNA research has advanced rapidly, becoming a key component of modern therapeutics. This review outlines key milestones and innovations from antisense oligonucleotides and RNA interference to mRNA therapies and aptamers that have enabled targeted treatments for diverse diseases. The…

  8. Artikel Jurnal

    A systems-level machine learning approach uncovers therapeutic targets in clear cell renal cell carcinoma

    Silas Ruhrberg Estévez; Greta Baltusyte; Gehad Youssef dkk.

    npj Drug Discovery, Vol. 3 No. 1 · 2026 · Inggris · DOAJ

    Abstract Clear cell renal cell carcinoma (ccRCC) is an aggressive malignancy with limited treatment options and high rates of resistance to first-line kinase inhibitors. Current therapies largely target the tumor microenvironment, leaving intrinsic tumor vulnerabilities underexplored. Here, we…

  9. Artikel Jurnal

    A genetics-guided integrative framework for drug repurposing: identifying antihypertensive drugs for type 2 diabetes

    Xue Zhong; Qiang Wei; Anshul Tiwari dkk.

    npj Drug Discovery, Vol. 3 No. 1 · 2026 · Inggris · DOAJ

    Abstract Genetics-informed drug repurposing holds promise in translating genetic findings into therapeutics. In this study, we developed a Genetics Informed Network-based Drug Repurposing via in silico Perturbation (GIN-DRIP) framework and applied the framework to repurpose drugs for type-2…

  10. Artikel Jurnal

    AI-guided competitive docking for virtual screening and compound efficacy prediction

    Manon Mirgaux; Valeria Barcelli; Adeline C. Y. Chua dkk.

    npj Drug Discovery, Vol. 3 No. 1 · 2026 · Inggris · DOAJ

    Abstract Machine learning has revolutionized protein structure and interaction prediction, yet its full potential for drug discovery is still emerging. In this study, we show that denoise diffusion-based co-folding methods—such as AlphaFold3 and Boltz-1/2—not only achieve highly accurate…

  11. Artikel Jurnal

    Harnessing snake venom cardiotoxins for antimicrobial peptide discovery

    Bruno Mendes; José R. Almeida; Valeria Castelletto dkk.

    npj Drug Discovery, Vol. 3 No. 1 · 2026 · Inggris · DOAJ

    Abstract Snake venoms are a rich source of bioactive molecules with considerable potential for drug discovery. Cardiotoxins (CTXs) from cobras (Naja spp.) are membrane-active venom proteins and promising templates for antimicrobial peptide development. Here, we combined two computational…

  12. Artikel Jurnal

    Spider venom peptides Ht1a and Gg1a are toxic to honeybee parasite Varroa destructor by topical application

    Volker Herzig; Shaodong Guo; David A. Eagles dkk.

    npj Drug Discovery, Vol. 3 No. 1 · 2026 · Inggris · DOAJ

    Abstract Global food supply strongly depends on honeybee pollination services, which are threatened by insecticides and pests such as parasitic Varroa destructor mites. Chemical varroacides/acaricides are hampered by resistance development, necessitating the development of sustainable and…

  13. Artikel Jurnal

    Mechanistic and therapeutic insights into class A GPCR dimers in neuropsychiatric disorders

    Zhaojing Wang; Linlin Wang; Shicheng Zhang

    npj Drug Discovery, Vol. 3 No. 1 · 2026 · Inggris · DOAJ

    Abstract Class A G protein-coupled receptors (GPCRs) constitute the majority of the clinical GPCR targets and are implicated in a wide range of neuropsychiatric disorders. Dimerization of class A GPCRs often introduces unique modes of allosteric modulation, leading to the reprogramming of the…

  14. Artikel Jurnal

    Assessing the ligand native-like pose using a quantum mechanical-derived hydropathic score for protein-ligand complementarity

    Brian Medel-Lacruz; William J. Zamora; Enric Herrero dkk.

    npj Drug Discovery, Vol. 3 No. 1 · 2026 · Inggris · DOAJ

    Abstract Elucidating the correct binding mode of drug-like compounds is crucial to reveal the molecular determinants underlying the recognition by the target protein and to estimate the binding affinity, thus guiding ensuing hit-to-lead optimization. However, identifying the near-native binding…

  15. Artikel Jurnal

    Discovery and preclinical validation of a translationally optimized mitochondrial complex I modulator for Alzheimer’s disease

    Sergey Trushin; Thi Kim Oanh Nguyen; Mark Ostroot dkk.

    npj Drug Discovery, Vol. 3 No. 1 · 2026 · Inggris · DOAJ

    Abstract Alzheimer’s disease (AD) is characterized by progressive metabolic failure, impaired mitochondrial function, and diminished adaptive stress responses, highlighting the need for disease-modifying therapies that restore cellular resilience rather than target downstream pathology. Here, we…

  16. Artikel Jurnal

    Pushing the boundaries of virtual screening scale of combinatorial spaces with the V-SYNTHES approach

    Mykola Protopopov; Olha Semenenko; Maryna Vasylchuk dkk.

    npj Drug Discovery, Vol. 3 No. 1 · 2026 · Inggris · DOAJ

    Abstract Computational screening of giga-scale chemical spaces opens a cost-effective path to high-quality hit identification, providing entry points for drug discovery. As these on-demand spaces grow and successful applications multiply, rigorous blind benchmarks like CACHE Challenges provide…

  17. Artikel Jurnal

    Considerations for the dynamic role of bile acids during oral drug discovery and development

    Zahraa Al-Tamimi; Michael J. Hageman

    npj Drug Discovery, Vol. 3 No. 1 · 2026 · Inggris · DOAJ

    Abstract Knowledge of gastrointestinal media is crucial for developing successful oral drug products. Bile acids are an essential component in the intestinal lumen, influencing the behavior of orally administered molecules. This review addresses the various roles of bile acids in drug discovery and…

  18. Artikel Jurnal

    Data driven selection of consensus docking pipelines for structure based hit identification

    Hamza Agha; Youssef Ibrahim; Michael Backenköhler dkk.

    npj Drug Discovery, Vol. 3 No. 1 · 2026 · Inggris · DOAJ

    Abstract Structure-based virtual screening (SBVS) is a cornerstone of computer-aided drug design, yet its success depends on selecting a combination of docking tools, scoring function (SF), and ranking strategies. MolDockLab addresses this challenge with an automated, data-driven framework that…

  19. Artikel Jurnal

    A curated benchmark for cofolding models on kinase conformational states

    Kunyang Sun; Teresa Head-Gordon

    npj Drug Discovery, Vol. 3 No. 1 · 2026 · Inggris · DOAJ

    Abstract Protein kinases are critical drug targets, requiring therapeutics that can modulate their active and inactive conformational states. While cofolding models can generate global folds directly from kinase sequences and ligand SMILES strings, these models have not yet been tested on their…